Alpha-methylstyrene (AMS) is a colorless liquid with a sweet, aromatic odor. It is a monomer used in the production of polymers, such as polystyrene and synthetic rubber. AMS is synthesized by the dehydration of alpha-methylbenzyl alcohol, which can be obtained by the reduction of acetophenone. AMS is a reactive compound that readily undergoes polymerization. It can also undergo various other reactions, such as oxidation and halogenation. AMS is used in the production of a wide variety of products, including plastics, resins, adhesives, and elastomers. It is also used as a solvent and as a component of fuels and lubricants. AMS is known to be a potential human health hazard. Inhalation, ingestion, or skin contact can cause irritation and other health problems. The compound is also flammable and should be handled with care. AMS is a valuable industrial chemical, but it is also a potential environmental pollutant. Its release into the environment can have negative effects on aquatic life and human health. Research on AMS is ongoing, focusing on areas such as its synthesis, reactivity, and potential environmental impact.'
ID Source | ID |
---|---|
PubMed CID | 7407 |
CHEMBL ID | 1344773 |
CHEBI ID | 35060 |
MeSH ID | M0069048 |
Synonym |
---|
BIDD:ER0701 |
a-methylstyrene |
AKOS009031371 |
BB 0220511 |
isopropenyl-benzene |
ccris 6067 |
isopropenyl-benzol [german] |
isopropenyl-benzeen [dutch] |
einecs 202-705-0 |
alpha-metil-stirolo [italian] |
1-methylethylenebenzene |
styrene, alpha-methyl- |
alpha-methylstyreen [dutch] |
isopropenil-benzolo [italian] |
a-methyl styrene |
hsdb 196 |
ai3-18133 |
un2303 |
1-methylethenylbenzine |
1-methyl-1-phenylethene |
alpha-methyl-styrol [german] |
alpha-methyl styrene |
nsc 9400 |
as-methylphenylethylene |
.alpha.-methyl-styrol |
nsc9400 |
2-phenylpropene |
2-phenyl-1-propene |
1-propene, 2-phenyl- |
1-phenyl-1-methylethylene |
1-methyl-1-phenylethylene |
isopropenyl-benzol |
isopropenylbenzene |
isopropenil-benzolo |
nsc-9400 |
benzene, (1-methylethenyl)- |
.alpha.-metil-stirolo |
.beta.-phenylpropene |
2-phenylpropylene |
.alpha.-methylstyrol |
98-83-9 |
.beta.-phenylpropylene |
.alpha.-methylstyrene |
styrene, .alpha.-methyl- |
isopropenyl-benzeen |
.alpha.-methylstyreen |
wln: 1yr & u1 |
(1-methylethenyl)benzene |
ortho brush killer a |
2-phenyl-2-propene |
beta-phenylpropene |
alpha-methylstyrol |
alpha-methylstyrene |
beta-phenylpropylene |
inchi=1/c9h10/c1-8(2)9-6-4-3-5-7-9/h3-7h,1h2,2h |
NCGC00090741-01 |
GHL.PD_MITSCHER_LEG0.286 |
alpha-methylstyrene, 99%, contains 15 ppm p-tert-butylcatechol as inhibitor |
MLS001055493 |
smr000686066 |
prop-1-en-2-ylbenzene |
alpha-menthylstyrene |
M0429 |
NCGC00090741-02 |
HMS3039N11 |
cas-98-83-9 |
NCGC00257713-01 |
tox21_200159 |
dtxsid9025661 , |
dtxcid905661 |
25014-31-7 |
alpha methylstyrene |
unii-d46r9753ik |
d46r9753ik , |
isopropenylbenzene [un2303] [flammable liquid] |
alpha-metil-stirolo |
alpha-methylstyreen |
alpha-methyl-styrol |
ec 202-705-0 |
FT-0613309 |
alpha-methylstyrene [hsdb] |
.alpha.-methylvinylbenzene |
1-methylvinyl benzene |
2-phenyl-1-propylene |
alpha-methyl-styrene |
benzene, isopropenyl- |
alphamethyl styrene |
2-phenyl-propene |
2-phenylprop-1-ene |
alphamethylstyrene |
CHEMBL1344773 |
CHEBI:35060 , |
un 2303 |
mfcd00008859 |
J-510246 |
alpha-methylstyrene, stabilized |
F0001-2321 |
(1-methylethenyl)-benzene contains 15 ppm p-tert-butylcatechol as inhibitor |
alpha-methylstyrene monomer, analytical standard |
alpha-methylstyrene (stabilized with tbc) |
alpha-methylstyrene, 99%, contains 15 ppm 4-tert-butylcatechol as stabilizer |
CS-W004075 |
Q414195 |
alpha -methylstyrene monomer |
BS-22949 |
(prop-1-en-2-yl)benzene |
EN300-19672 |
Excerpt | Relevance | Reference |
---|---|---|
" The highest tissue (14)C levels in rats were observed in adipose tissue, liver, and kidney with no accumulation observed after repeat dosing up to 7 days." | ( Disposition and metabolism of cumene in F344 rats and B6C3F1 mice. Chen, LJ; Dix, KJ; Kramer, DJ; McDonald, JD; Sanders, JM; Thomas, LA; Wegerski, CJ, 2011) | 0.37 |
Class | Description |
---|---|
olefinic compound | Any organic molecular entity that contains at least one C=C bond. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 89.1251 | 0.1000 | 20.8793 | 79.4328 | AID588453 |
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 6.8590 | 0.0060 | 38.0041 | 19,952.5996 | AID1159521 |
AR protein | Homo sapiens (human) | Potency | 48.7177 | 0.0002 | 21.2231 | 8,912.5098 | AID1259247; AID743042 |
progesterone receptor | Homo sapiens (human) | Potency | 8.2007 | 0.0004 | 17.9460 | 75.1148 | AID1346784; AID1347036 |
glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 48.9782 | 0.0002 | 14.3764 | 60.0339 | AID720692 |
retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 28.6407 | 0.0008 | 17.5051 | 59.3239 | AID1159527; AID1159531 |
peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 0.0063 | 0.0010 | 24.5048 | 61.6448 | AID588535 |
IDH1 | Homo sapiens (human) | Potency | 1.0323 | 0.0052 | 10.8652 | 35.4813 | AID686970 |
chromobox protein homolog 1 | Homo sapiens (human) | Potency | 63.0957 | 0.0060 | 26.1688 | 89.1251 | AID540317 |
thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 8.9125 | 0.0100 | 39.5371 | 1,122.0200 | AID588545 |
importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 0.5174 | 5.8048 | 36.1306 | 65.1308 | AID540253 |
snurportin-1 | Homo sapiens (human) | Potency | 0.5174 | 5.8048 | 36.1306 | 65.1308 | AID540253 |
GTP-binding nuclear protein Ran isoform 1 | Homo sapiens (human) | Potency | 0.5174 | 5.8048 | 16.9962 | 25.9290 | AID540253 |
DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 89.1251 | 0.0501 | 27.0736 | 89.1251 | AID588590 |
lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 2.5119 | 0.0200 | 10.7869 | 31.6228 | AID912 |
Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 0.5956 | 0.0266 | 22.4482 | 66.8242 | AID651802 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
nucleus | Nuclear receptor ROR-gamma | Homo sapiens (human) |
nucleoplasm | Nuclear receptor ROR-gamma | Homo sapiens (human) |
nuclear body | Nuclear receptor ROR-gamma | Homo sapiens (human) |
chromatin | Nuclear receptor ROR-gamma | Homo sapiens (human) |
nucleus | Nuclear receptor ROR-gamma | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 7 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (19.05) | 29.6817 |
2010's | 8 (38.10) | 24.3611 |
2020's | 2 (9.52) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (45.70) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 23 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |